Arcutis Biotherapeutics Inc Working Capital to Net Assets Ratio
Arcutis Biotherapeutics Inc working capital to net assets ratio. Arcutis Biotherapeutics Inc (ARQT) has a Working Capital to Net Assets ratio of 139.3% as of June 2026. Working capital of $307.33 Million (current assets of $467.67 Million minus current liabilities of $160.34 Million) is measured against net assets of $220.58 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Arcutis Biotherapeutics Inc (2017–2025)
Working capital to net assets ratio of Arcutis Biotherapeutics Inc from 2017 to 2025. This chart shows how Arcutis Biotherapeutics Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 139.3%, reflecting working capital of $307.33 Million against net assets of $220.58 Million USD. See defensive interval ratio of Arcutis Biotherapeutics Inc to measure how many days the company can operate on defensive assets alone.
Arcutis Biotherapeutics Inc Working Capital to Net Assets Ratio by Year (2017–2025)
Arcutis Biotherapeutics Inc working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Arcutis Biotherapeutics Inc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Arcutis Biotherapeutics Inc total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 148.5% | $281.39 Million | $189.48 Million | $411.23 Million | $129.84 Million | ▼ -13.2 pp |
| 2024 | 161.7% | $254.81 Million | $157.54 Million | $335.82 Million | $81.01 Million | ▼ -158.3 pp |
| 2023 | 320.0% | $283.76 Million | $88.67 Million | $330.43 Million | $46.67 Million | ▲ +129.4 pp |
| 2022 | 190.7% | $399.60 Million | $209.58 Million | $437.41 Million | $37.81 Million | ▲ +66.6 pp |
| 2021 | 124.1% | $369.45 Million | $297.68 Million | $402.77 Million | $33.33 Million | ▲ +24.3 pp |
| 2020 | 99.9% | $270.22 Million | $270.62 Million | $292.83 Million | $22.60 Million | ▲ +0.1 pp |
| 2019 | 99.8% | $101.24 Million | $101.46 Million | $106.47 Million | $5.24 Million | ▲ +301.7 pp |
| 2018 | -201.9% | $48.42 Million | $-23.99 Million | $51.10 Million | $2.67 Million | ▼ -139.3 pp |
| 2017 | -62.6% | $3.13 Million | $-4.99 Million | $3.82 Million | $692.00K | — |